F
38
4
MSI
52
3
CRM
65
6
TXN
29
4
IVZ
42
13
HIG
48
5
UAL
73
3
WMT
68
-2
MTB
38
4
DGX
28
4
AIG
38
5
CNX
67
4
DTE
49
16
IPG
43
3
ZTS
38
4
AAPL
64
3
NDAQ
46
2
AZO
46
3
SHW
42
5
EXPD
29
2
F
38
4
MSI
52
3
CRM
65
6
TXN
29
4
IVZ
42
13
HIG
48
5
UAL
73
3
WMT
68
-2
MTB
38
4
DGX
28
4
AIG
38
5
CNX
67
4
DTE
49
16
IPG
43
3
ZTS
38
4
AAPL
64
3
NDAQ
46
2
AZO
46
3
SHW
42
5
EXPD
29
2
Financhill
Back

Sangamo Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Buy
57

SGMO
Sangamo Therapeutics

Last Price:
$2.48
Seasonality Move:
11.45%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Buy
57
Sangamo Therapeutics (SGMO) is a Buy

Is Sangamo Therapeutics a Buy, Sell or Hold?

  • The current Sangamo Therapeutics [SGMO] share price is $2.49. The Score for SGMO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • SGMO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SGMO Stock Price Chart

What is Sangamo Therapeutics's stock price today?

  • The Sangamo Therapeutics share price today is $2.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SGMO is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

SGMO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 58.33 Buy
Chaikin Money Flow: 9258844 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.88 - 2.38) Buy
Bollinger Bands (100): (0.73 - 2.07) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.72 - 15.04) Sell

SGMO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.31 Buy
20-day SMA: 2.17 Buy
50-day SMA: 1.94 Buy
200-day SMA: 0.98 Buy
8-day EMA: 2.35 Buy
20-day EMA: 2.21 Buy
50-day EMA: 1.93 Buy
200-day EMA: 1.25 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.99 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.01 Sell

Sangamo Therapeutics Earnings Growth & SGMO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.32 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Sangamo Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):